Suven Life Sciences rises on securing three product patents in Europe and Eurasia

29 Jun 2016 Evaluate

Suven Life Sciences is currently trading at Rs. 206.40, up by 2.20 points or 1.08% from its previous closing of Rs. 204.20 on the BSE.

The scrip opened at Rs. 206.40 and has touched a high and low of Rs. 210.30 and Rs. 203.20 respectively. So far 66,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 308.70 on 05-Oct-2015 and a 52 week low of Rs. 144.35 on 19-Feb-2016.

Last one week high and low of the scrip stood at Rs. 210.30 and Rs. 182.10 respectively. The current market cap of the company is Rs. 2,634.75 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 7.74% and 32.25% respectively.

Suven Life Sciences (Suven) has been granted one product patent from Europe (2507225) and two product patents from Eurasia (023293 and 023260) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029, 2030 and 2031 respectively.

The granted claims of the patents are from the mechanism of action include the class of selective 5?HT4 compounds, Alpha4Beta2 and H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, the company has a total of twenty one granted patents from Europe and nineteen granted patents from Eurasia. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out?licensed at various phases of clinical development like at Phase?I or Phase?II.


Suven Life Sciences Share Price

166.85 -0.60 (-0.36%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×